Science in Sport plc
(the "Company" or "Group")
Board Changes
Further to the announcement of 28 September 2023, Science in Sport plc (AIM: SIS), the premium performance nutrition company serving elite athletes, sports enthusiasts, and the active lifestyle community, is pleased to confirm the appointment of Dan Wright as Non-Executive Chairman with immediate effect. Dan Wright replaces John Clarke, who has now stepped down from the Company's Board.
The following information is disclosed pursuant to Rule 17 and Schedule 2(g) of the AIM Rules for Companies.
The names of all companies and partnerships of which Daniel Patrick Wright, aged 51, is, or has been a director or partner at any time in the previous five years are set out below:
| Current directorships or partnerships: | Previous directorships or partnerships (in the last five years): |
| Accrol Group Holdings PLC | Blackburn Youth Zone |
| Atom Partners Limited | Highflex Holdings (UK) Limited |
| Gomrath Limited | Vision Linens Global Limited |
| Manchester and London Investment Trust Plc | Vision Linens Group Limited |
| SolasCure Limited | Vision Support Services Asia Limited |
| Uinsure Commercial Limited | Vision Support Services Pakistan (Pvt) Ltd |
| Uinsure Holdings Limited | VSS Sourcing (India) Private Limited |
| Uinsure Limited | |
Dan Wright was a director of Highflex Holdings (UK) Limited which went into administration on 2 August 2017 and was dissolved following liquidation on 14 November 2018.
Dan Wright holds an interest in 706,141 contracts for difference in Science in Sport plc.
Save as set out in this announcement, there are no further details to be disclosed under Rule 17 or Schedule 2(g) of the AIM Rules for Companies in respect of Dan Wright.
For further information:
| Science in Sport plc | T: 020 7400 3700 |
| Stephen Moon, CEO Daniel Lampard, CFO
| |
| | |
| Liberum (Nominated Adviser and Broker) | T: 020 3100 2000 |
| Richard Lindley / Anake Singh
| |
Notes to Editors
About Science in Sport plc
Headquartered in London, Science in Sport plc is a leading sports nutrition business that develops, manufactures, and markets innovative nutrition products for professional athletes, sports and fitness enthusiasts and the active lifestyle community. The Company has two highly regarded brands, PhD Nutrition, a premium active-nutrition brand targeting the active lifestyle community, and SiS, a leading endurance nutrition brand among elite athletes and professional sports teams.
The two brands sell through the Company's phd.com and scienceinsport.com digital platforms, third-party online sites, including Amazon and Tmall, and extensive retail distribution in the UK and internationally, including major supermarkets, high street chains and specialist sports retailers. This omnichannel footprint enables the Company to address the full breadth of the sports nutrition market, forecast to be £13 billion1 worldwide by 2023.
PhD is one of the UK's leading active nutrition brands with a reputation for high quality and product innovation. The brand has grown rapidly since its launch in 2005. The range now comprises powders, bars, and supplements, including the high protein, low sugar range, PhD Smart. PhD brand ambassadors include leading fitness influencers Ross Edgley and Obi Vincent.
SiS, founded in 1992, has a core range comprising gels, powders and bars focused on energy, hydration, and recovery. SiS is an official sports nutrition supplier to over 330 professional teams, organisations, and national teams worldwide, including INEOS Grenadiers Cycling Team. SiS supplies more than 150 professional football clubs in the UK, Europe, and the USA. SiS is Performance Research Partner to the English Football Association and Official Vitamins and Supplements Partner to the Milwaukee Bucks, 2021 National Basketball Association Champions.
For further information, please visit phd.com and scienceinsport.com
1 Euromonitor Passport Database Global Assessment (December 2020)
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.